טוען...
Rhaponticin suppresses osteosarcoma through the inhibition of PI3K-Akt-mTOR pathway
Osteosarcoma is the frequent pediatric bone cancer where pediatric osteosarcoma incidences are more than 10% within the population. Most of the patients with osteosarcoma fall within the age of 15–30 years. Therefore, in this research, we examined the anticancer effect of Rhaponticin against the hum...
שמור ב:
| הוצא לאור ב: | Saudi J Biol Sci |
|---|---|
| Main Authors: | , , , , , , |
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
Elsevier
2021
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8241634/ https://ncbi.nlm.nih.gov/pubmed/34220214 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.sjbs.2021.05.006 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|